Dr. Stuart W. Peltz is a seasoned leader in the biotechnology industry, having co-founded PTC Therapeutics, Inc. and serving as its CEO since its inception in 1998 until March 2023. He holds a Ph.D. in Molecular Biology from the University...

Dr. Stuart W. Peltz is a seasoned leader in the biotechnology industry, having co-founded PTC Therapeutics, Inc. and serving as its CEO since its inception in 1998 until March 2023. He holds a Ph.D. in Molecular Biology from the University of Pennsylvania and is recognized for his expertise in RNA biology. Under his leadership, PTC Therapeutics has focused on developing cutting-edge therapies for rare genetic diseases and has made notable advancements in the biotech field. Dr. Peltz retired in early 2023, but he continues to contribute to the company as a Senior Advisor and member of the Scientific Advisory Board. His health expertise and management experience led PTC to achieve significant successes and build a strong reputation within the industry. In 2023, his total compensation reached about $5.7 million, which involved a salary, stock options, and other benefits, reflecting his substantial contributions and value to the company. Throughout his career, Dr. Peltz has also received accolades, including being named in PharmaVoice's 100 Most Inspiring People. His work has helped shape modern biopharmaceutical innovation, making him a key figure in the landscape of biotechnology.

Quick Links

1. Rivals

2. Holdings

3. Insider Trading

4. Compensation History

5. Other PTC Therapeutics CEOs

P

Dr. Stuart W. Peltz

Founder and Ex-CEO of PTC Therapeutics

Education

Ph.D. in Molecular Biology from the University of Pennsylvania

Field of Expertise

Healthcare & Life Sciences - Biotechnology

Sector of Economy

Healthcare

Born

January 1, 1963 - 62 years ago

CEO of PTC Therapeutics for

10 years 2 months (Jan 2013 - Mar 2023)

Previous Experience

Founder and CEO of PTC Therapeutics, Inc. since its inception.

Rivals

Competitors/colleagues of Dr. Stuart W. Peltz

Holdings

See how much did Dr. Stuart W. Peltz make over time.

Dr. Peltz's wealth has been closely tied to PTC Therapeutics, where he held a notable stake. As of his retirement in March 2023, he held approximately 1.5 million shares and stock options. Over the years, his holdings experienced fluctuations, peaking...

Dr. Peltz's wealth has been closely tied to PTC Therapeutics, where he held a notable stake. As of his retirement in March 2023, he held approximately 1.5 million shares and stock options. Over the years, his holdings experienced fluctuations, peaking during significant company milestones. His stock value, particularly at the peak of PTC's progress, represented a considerable portion of his wealth. In 2020 alone, the total value of his holdings and other compensations was reported to be over $100 million, marking a pinnacle in his financial portfolio. After his retirement, his stock options and restricted shares will continue to vest based on the consulting agreement he has with PTC Therapeutics, illustrating a continued connection to the company's future success.

No data yet.

Total Stock Sold

$88.32M

PTCT

$88.32M

1,592,180 PTCT shares

What if they kept their stock?

If Dr. Stuart W. Peltz didn't sell their stock, today they would have:
Extra PTCT1,592,180 shares worth $80.74M.
This is -8.58% and $7.58M less than what they got when they sold the stock.

Insider Trading

See recent insider trades of Dr. Stuart W. Peltz.

PTCT

$119.59K

PTCT at $45.63/share

Jan 31, 2023

Sale

PTCT

$13.48K

PTCT at $47.45/share

Jan 24, 2023

Sale

PTCT

$151.89K

PTCT at $43.65/share

Jan 10, 2023

Sale

PTCT

$86.02K

PTCT at $41.66/share

Jan 9, 2023

Sale

PTCT

71,000 shares

PTCT

Jan 5, 2023

Received

PTCT

$10.92K

PTCT at $26.83/share

Jun 7, 2022

Sale

PTCT

$3.71K

PTCT at $45.28/share

Apr 14, 2022

Sale

PTCT

$89.72K

PTCT at $40.00/share

Feb 1, 2022

Sale

PTCT

$12.97K

PTCT at $39.31/share

Jan 25, 2022

Sale

PTCT

$83.33K

PTCT at $38.53/share

Jan 7, 2022

Sale

Compensation History

See how much did Dr. Stuart W. Peltz make over time.

In 2023, Dr. Stuart W. Peltz's total compensation was approximately $5.7 million, which included a base salary of $188,033 and over $2 million in vested stock units. He did not receive any bonuses due to his retirement prior to the bonus payout period. In earlier years, particularly in 2020, his compensation was significantly higher, peaking at around $100 million due to the value of his stock options and other incentives. Dr. Peltz's compensation structure was designed to align with company performance, which is a standard practice in executive compensation, but his absence of bonus payout in 2023 reflects the transitional phase of his retirement. His compensation history emphasizes the volatility in biotech leadership roles and the importance of aligning incentives with company milestones.

Year

2023

Total Compensation

$2.89M

Salary

$188.03K

Board Justification

The compensation philosophy focuses on aligning executive compensation with company performance and shareholder interests, with a significant portion being 'at risk'.

Bonus

$0.00

Board Justification

No bonus was awarded for 2023 due to retirement before the bonus payout period.

Other

$608.87K

Board Justification

Includes payments for accrued but unused vacation days and payments under the Consulting Agreement.

Restricted Stock

$2.09M(53K RSU)

Board Justification

53,000 restricted stock units vested in 2023, granted prior to retirement.

Performance Metrics

Performance metrics included achieving corporate goals related to financial performance, commercial success, and advancing clinical programs.

Other PTC Therapeutics CEOs

Here are other CEOs of PTC Therapeutics

Dr. Matthew B. Klein

CEO of PTC Therapeutics

March 2023 - Present